{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "2379277", "DateCompleted": {"Year": "1990", "Month": "09", "Day": "10"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "05"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0009-2363", "JournalIssue": {"Volume": "38", "Issue": "4", "PubDate": {"Year": "1990", "Month": "Apr"}}, "Title": "Chemical & pharmaceutical bulletin", "ISOAbbreviation": "Chem Pharm Bull (Tokyo)"}, "ArticleTitle": "The antiulcer action of sophora and the active constituent in Sophora. II. The antiulcer action of vexibinol.", "Pagination": {"StartPage": "1039", "EndPage": "1044", "MedlinePgn": "1039-44"}, "Abstract": {"AbstractText": ["The inhibitory effect of vexibinol, one of the flavanols found in Sophora, on gastric ulcers induced by HCl-ethanol has been reported previously. In the present study, the effect of vexibinol was examined in various experimental ulcer models in order to determine the mechanism of its antiulcer action. The results indicated that the oral administration of vexibinol at 25-50 mg/kg significantly inhibited the development of ulcers induced by HCl-ethanol, 0.6 N HCl 0.2 N NaOH, absolute ethanol and 1% NH3. In addition, an intraduodenal administration of vexibinol at 300 mg/kg significantly inhibited Shay's ulcer. Further, intraduodenal administration at 300 mg/kg significantly inhibited acid secretion caused by 2-deoxy-D-glucose. These results suggest that vexibinol has not only gastric mucosal protective action but also an inhibitory effect on the secretion of gastric acids."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kyoto Pharmaceutical University, Japan."}], "LastName": "Yamahara", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mochizuki", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Chisaka", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Fujimura", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tamai", "ForeName": "Y", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Chem Pharm Bull (Tokyo)", "NlmUniqueID": "0377775", "ISSNLinking": "0009-2363"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Ulcer Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavanones"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "97938-30-2", "NameOfSubstance": "vexibinol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Anti-Ulcer Agents"}, {"QualifierName": [], "DescriptorName": "Flavanones"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["metabolism"], "DescriptorName": "Gastric Acid"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["analysis"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Inbred Strains"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Stomach Ulcer"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1990", "Month": "4", "Day": "1"}, {"Year": "1990", "Month": "4", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1990", "Month": "4", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["2379277", "10.1248/cpb.38.1039"]}}]}